Skip to content

Efficacy of Lower Limb Exercises on Overactive Bladder Symptoms in Patients With Multiple Sclerosis

Efficacy of Isometric Contraction Exercises of Lower Limbs Muscles, in Modulating Neurological Control of Bladder Function in Patients With Multiple Sclerosis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03322748
Enrollment
30
Registered
2017-10-26
Start date
2018-02-28
Completion date
2020-02-29
Last updated
2018-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, Muscle Strain, Overactive Bladder Syndrome

Brief summary

The aim of the study (OVERACT\_V1) is to verify if the isometric contraction of ankle plantarflexor and Hamstring muscles, induces a significant reduction of overactive bladder symptoms in patients with Multiple sclerosis.

Detailed description

The aim of the study (OVERACT\_V1) is to verify if the isometric contraction of ankle plantarflexor and Hamstring muscles, induces a significant reduction of overactive bladder symptoms in patients with Multiple sclerosis. It's known that the electric stimulation of the Posterior Tibial nerve induces an improvement of overactive bladder symptoms through a modulation of spinal circuitry, which occurs with unknown mechanisms. The investigators' hypothesis is that the voluntary muscular activation may induce a modulation of the sacral root as long as the electric stimulation. 30 patients will be recruited within 2 years, since October 2017 through October 2019. This is a monocentric, randomized controlled , in single blind, not pharmacological study.

Interventions

OTHERUsual physical therapy+ strengthening of lower limbs muscles

Experimental group will perform usual physical therapy plus 3 series of isometric contractions of ankle plantarflexor and Hamstring muscles bilaterally, each lasting 5 seconds.

Usual physical therapy

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Multiple Sclerosis Patients * Urge score \>=2 * urinary daytime frequency \>=8 * stable overactive bladder symptoms for 6 months * MRC ( Medical Research Council) scale of ankle plantarflexors and hamstrings \>=2 * signed informed consensus

Exclusion criteria

* FIM ( Functional Independence Measure) memory items \<=4 * impairment in registering bladder diary * inclusion in other experimental study * specific straightening during the suty period * PVR \>= 200 ml ina single evaluation or PVR (post void residual) \>=150 in 4 evaluation (twice a day for 2 consecutive days) * Urinary infections * concomitant urological disease * intrathecal baclofen pump * SANS (Stoller Afferent Nerve Stimulation) * modification of therapy for overactive bladder symptoms within three months before entering the study

Design outcomes

Primary

MeasureTime frameDescription
Change of Urinary frequencyat 6th and 22nd daymean of voluntary urination episodes daytime during 4 days of bladder diary
Change of Urge scoreat 6th and 22nd daymean of score evaluating the perception of urge that patient experiences every urination. The subscale scores are: * 0, if patient doesn't need to urinate, but urinates before going out from home or concerned about the unavailability of toilet; * 1, if patient doesn't experience urgent urination; * 2, presence of urgency but disappeared before getting to the toilet; * 3, presence of urgency and reached the toilet without leakage of urine * 4, presence of urgency and did not reach the toilet with leakage of urine
Change of total score of OAB-q ( Overact Bladder questionnaire) long format 3rd and 18th dayquestionnaire evaluates the impact of overactive bladder symptoms on activities of daily living 8 ITEMS SYMPTOM BOTHER (each item has a subscale score from 1 to 6) + 25 ITEMS HEALTH-RELATED QUALITY OF LIFE (each item has a subscale score from 1 to 6)

Secondary

MeasureTime frameDescription
Change of episodes of nocturiaat 6th and 22nd dayMean of voluntary urination episodes nightime during 4 days of bladder diary
Change of Postvoid Residual Volumeat 3rd and 18th dayMean of 3 measurement of Urine residual after voluntary voiding
Change of Pad-test 24 Hoursat 6th and 22nd dayMean of numbers and weight of pads
Change of value at Uroflussimetryat 3rd and 18th dayMean of maximum urinary flow rate (Qmax) value at uroflussimetry
PGI (Patient global impression of improvement)at 18th dayQuestionnaire on subjective impression of improvement of overactive bladder symptoms
Change of EDSS (Expanded Disability Status Scale)at 2nd and 22nd dayMean of value at EDSS that quantifying disability in multiple sclerosis
Change of Barthel Index Scoreat 2nd and 22nd dayMean of total score measuring performance in activities of daily living
Change of MAS (Modified Ashworth Scale )at 2nd and 22nd dayMean of score (0-4) measuring spasticity of plantarflexors and Hamstring muscles
Change of value at H REFLEX testat 6th and 22nd dayEvaluation of H wave mean amplitude and of Ratio of maximum H reflex to maximum M response after a train of stimuli given at 1 and 0.1 Hz
Change of Urine volumeat 6th and 22nd dayMinimum , maximum and mean of urine volume voiding during 4 days of bladder diary
Change of episodes of urinary incontinenceat 6th and 22nd dayMean of involuntary leakage of urine during 4 days of bladder diary

Countries

Italy

Contacts

Primary ContactGiancarlo Comi, MD
giancarlo.comi@hsr.it0226432990
Backup ContactValentina Grazioli, PT
grazioli.valentina@hsr.it0226432928

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026